Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

VELCADE in Subjects With Relapsed or Refractory Mantle Cell Lymphoma

This study has been completed.
Information provided by:
Millennium Pharmaceuticals, Inc. Identifier:
First received: July 2, 2003
Last updated: February 7, 2008
Last verified: February 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)